{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T19:56:12Z","timestamp":1648929372000},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Comput Math Organ Theory"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10588-016-9223-3","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T15:34:37Z","timestamp":1464363277000},"page":"199-220","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generic substitution policy, an incentive approach"],"prefix":"10.1007","volume":"23","author":[{"given":"Aida Isabel","family":"Tavares","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"9223_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10198-007-0059-0","volume":"9","author":"V Aalto-Setala","year":"2008","unstructured":"Aalto-Setala V (2008) The impact of generic substitution on price competition in Finland. Eur J Health Econ 9:185\u2013191","journal-title":"Eur J Health Econ"},{"key":"9223_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/pds.1055","volume":"14","author":"K Andersson","year":"2005","unstructured":"Andersson K et al (2005) What are the obstacles to generic substitution? An assessment of the behavior of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiol Drug Saf 14:341\u2013348","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"9223_CR3","doi-asserted-by":"publisher","unstructured":"Birkett DJ (2003) Generics---equal or not? Aust Prescr, 26:85\u201387. \n                        http:\/\/www.australianprescriber.com\/upload\/pdf\/articles\/712\n                        \n                    . Accessed 2 April 2015","DOI":"10.18773\/austprescr.2003.063"},{"key":"9223_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.euroecorev.2013.02.005","volume":"61","author":"KR Brekke","year":"2013","unstructured":"Brekke KR et al (2013) Margins and market shares: pharmacy incentives for generic substitution. Eur Econ Rev 61:116\u2013131","journal-title":"Eur Econ Rev"},{"issue":"2","key":"9223_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1741134313515667","volume":"10","author":"A Brick","year":"2013","unstructured":"Brick A et al (2013) Usage of generics in Ireland: recent trends and policy developments. J Generic Med 10(2):72\u201385","journal-title":"J Generic Med"},{"key":"9223_CR6","unstructured":"Burtka AT (2007) Drug companies go too far to influence doctors, critics say, news & trends. Am Assoc Justice 43(10)"},{"issue":"1","key":"9223_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1057\/palgrave.jmm.5040144","volume":"24","author":"P Chandon","year":"2004","unstructured":"Chandon P (2004) Innovative marketing strategies after patent expiry, the case GSK\u2019s antibiotic Clamoxyl in France. Int J Med Mark 24(1):65\u201373","journal-title":"Int J Med Mark"},{"key":"9223_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1472-6963-11-17","volume":"11","author":"A Decollogny","year":"2011","unstructured":"Decollogny A et al (2011) Determinants of generic drug substitution in Switzerland. BMC Health Serv Res 11:17","journal-title":"BMC Health Serv Res"},{"key":"9223_CR9","unstructured":"Fuhrmans V (2008) Doctors paid to prescribe generic pills. Wall Street J Online"},{"issue":"5","key":"9223_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S1086-5802(16)31308-0","volume":"41","author":"CA Gaither","year":"2001","unstructured":"Gaither CA et al (2001) Consumers\u2019 view on generic medications. J Am Pharm Assoc 41(5):729\u2013736","journal-title":"J Am Pharm Assoc"},{"key":"9223_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0168-8510(00)00061-0","volume":"51","author":"L Garattini","year":"2000","unstructured":"Garattini L, Tediosi F (2000) A comparative analysis of generics market in five European countries. Health Policy 51:149\u2013162","journal-title":"Health Policy"},{"issue":"5","key":"9223_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2307\/4016523","volume":"168","author":"B Harder","year":"2005","unstructured":"Harder B (2005) Pushing drugs: how medical marketing influences doctors and patients. Sci News 168(5):75\u201376","journal-title":"Sci News"},{"key":"9223_CR13","unstructured":"Harris G (2004) Medical marketing\u2014treatment by incentives, as doctor writes prescription, drug company writes a check. New York Times, 27"},{"key":"9223_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jsps.2013.12.017","volume":"22","author":"MA Hassali","year":"2014","unstructured":"Hassali MA et al (2014) The experiences of implementing generic medicine policy in eight countries: a review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J 22:491\u2013503","journal-title":"Saudi Pharm J"},{"issue":"1","key":"9223_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2307\/2555818","volume":"29","author":"J Hellerstein","year":"1998","unstructured":"Hellerstein J (1998) The importance of the physician in the generic versus trade-name prescription decision. Rand J Econ 29(1):108\u2013136","journal-title":"Rand J Econ"},{"key":"9223_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0144-8188(00)00030-2","volume":"20","author":"J Hudson","year":"2000","unstructured":"Hudson J (2000) Generic take-up in the pharmaceutical market following patent expiry, a multi-country study. Int Rev Law Econ 20:205\u2013221","journal-title":"Int Rev Law Econ"},{"key":"9223_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jval.2015.08.014","volume":"18","author":"H Koskinen","year":"2015","unstructured":"Koskinen H et al (2015) Time series analysis on the impact of generic substitution and reference pricing on antipsychotic costs in Finland. Value Health 18:1105\u20131112","journal-title":"Value Health"},{"key":"9223_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.healthpol.2003.07.007","volume":"68","author":"J Lexchin","year":"2004","unstructured":"Lexchin J (2004) The effect of generic competition on the price of brand-name drugs. Health Policy 68:47\u201354","journal-title":"Health Policy"},{"issue":"1","key":"9223_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1745-6606.1980.tb00662.x","volume":"14","author":"J Mason","year":"1980","unstructured":"Mason J, Bearden W (1980) Generic drugs: consumer, pharmacist and physician perceptions on the issues. J Consum Aff 14(1):193\u2013206","journal-title":"J Consum Aff"},{"key":"9223_CR20","volume-title":"Demand for pharmaceutical drugs, a choice modelling experiment, WP 704\/2003","author":"A Merino-Castello","year":"2003","unstructured":"Merino-Castello A (2003) Demand for pharmaceutical drugs, a choice modelling experiment, WP 704\/2003. University Pompeu Fabra, Barcelona"},{"key":"9223_CR21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0167-7187(98)00057-5","volume":"18","author":"FMS Morton","year":"2000","unstructured":"Morton FMS (2000) Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry. Int J Ind Org 18:1085\u20131104","journal-title":"Int J Ind Org"},{"key":"9223_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hpm.816","volume":"20","author":"E Mossialos","year":"2005","unstructured":"Mossialos E, Oliver A (2005) An overview of pharmaceutical policy in four countries: France, Germany, Netherlands and UK. Int J Health Plan Manag 20:291\u2013306","journal-title":"Int J Health Plan Manag"},{"issue":"1","key":"9223_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1057\/palgrave.jgm.4950041","volume":"4","author":"G Perry","year":"2006","unstructured":"Perry G (2006) The European generic pharmaceutical market in review: 2006 and beyond. J Generic Med 4(1):4\u201314","journal-title":"J Generic Med"},{"key":"9223_CR24","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ijindorg.2007.08.004","volume":"26","author":"TL Regan","year":"2008","unstructured":"Regan TL (2008) Generic entry, price competition, and market segmentation in the prescription drug market. Int J Ind Org 26:930\u2013948","journal-title":"Int J Ind Org"},{"key":"9223_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10754-013-9126-5","volume":"13","author":"M Rischatsch","year":"2013","unstructured":"Rischatsch M (2013) Generic substitution, financial interests, and imperfect agency. Int J Health Care Financ Econ 13:115\u2013138","journal-title":"Int J Health Care Financ Econ"},{"key":"9223_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10198-005-0302-5","volume":"50","author":"L Tilson","year":"2005","unstructured":"Tilson L et al (2005) The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland. Eur J Health Econ 50:267\u2013273","journal-title":"Eur J Health Econ"},{"issue":"3","key":"9223_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.283.3.373","volume":"283","author":"A Wazana","year":"2000","unstructured":"Wazana A (2000) Physicians and the pharmaceutical industry, is a gift ever just a gift? JAMA 283(3):373\u2013380","journal-title":"JAMA"}],"container-title":["Computational and Mathematical Organization Theory"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10588-016-9223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10588-016-9223-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10588-016-9223-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10588-016-9223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:36:27Z","timestamp":1559302587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10588-016-9223-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["9223"],"URL":"https:\/\/doi.org\/10.1007\/s10588-016-9223-3","relation":{},"ISSN":["1381-298X","1572-9346"],"issn-type":[{"value":"1381-298X","type":"print"},{"value":"1572-9346","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}